MRTX Shares Outstanding History
Below is a table of the MRTX shares outstanding history going back to 7/15/2013:

Date MRTX Shares Outstanding
7/15/20139.96M
8/9/20139.96M
11/7/201313.26M
3/12/201413.48M
5/12/201413.48M
8/5/201413.53M
11/3/201413.54M
3/6/201516.16M
5/5/201516.18M
7/31/201516.41M
10/30/201519.27M
3/4/201619.30M
5/2/201619.91M
8/1/201619.92M
10/31/201619.92M
3/3/201724.94M
5/1/201724.94M
7/31/201724.97M
10/30/201725.30M
3/5/201828.94M
4/30/201829.05M
7/27/201832.36M
10/29/201832.52M
2/22/201935.27M
4/22/201936.05M
7/30/201939.30M
4/29/201145.56M
10/30/201939.44M
2/20/202043.48M
5/1/202043.64M
8/3/202044.54M
11/2/202050.28M
2/19/202150.63M
4/29/202151.44M

Also see: MRTX Market Cap History
MRTX YTD Return
MRTX Historical Shares Outstanding:
+23.45% CAGR
MRTX Historical Shares Outstanding: +23.45% CAGR

Mouse over chart for data details
7/15/2013 ...4/29/2021
Mirati Therapeutics is a clinical-stage oncology company developing product candidates to address the genetic and immunological promoters of cancer. Co.'s KRAS inhibitor program is focused on developing inhibitors of KRAS mutations and includes one clinical candidate and a preclinical program. Co. also has additional preclinical programs which include product candidates designed to address mutations and tumors where few treatment options exist. Co.'s clinical and preclinical programs consist of two product candidates: sitravatinib, a multi-kinase inhibitor and MRTX849, a KRAS G12C inhibitor. Co. has several discovery programs, including a preclinical program for a KRAS G12D inhibitor. We show 34 historical shares outstanding datapoints in our coverage of MRTX's shares outstanding history.

Understanding the changing numbers of MRTX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like MRTX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching MRTX by allowing them to research MRTX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for MRTX:
MRTX SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Mirati Therapeutics (MRTX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

MSON Shares Outstanding History
MTEM Shares Outstanding History
MYGN Shares Outstanding History
MYL Shares Outstanding History
MYND Shares Outstanding History
MYOK Shares Outstanding History
NAOV Shares Outstanding History
NBIX Shares Outstanding History
NDRA Shares Outstanding History
NEO Shares Outstanding History
More Healthcare companies »

 

MRTX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.